Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis

By sjmartinez • January 12, 2024

Shah A, Jones MP, Callaghan G, Fairlie T, Ma X, Culver EL, Stuart K, De Cruz P, O'Beirne J, Tabibian JH, Dignass A, Canbay A, Gores GJ, Holtmann GJ. Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis. Hepatol Commun. 2024 Jan 11;8(1):e0347. doi: 10.1097/HC9.0000000000000347. PMID: 38206197.

Tags: Digestive Diseases, Olive View DoM, Publications

Rates and Factors Associated With Hepatocellular Carcinoma Diagnosis, Stage, Treatment, and Survival

Ioannou GN, Yakovchenko V, Taddei T, Monto A, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John B, Blechacz[...]

The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease

Kim SG, Zhao MY, Lam C, Jacobs JP. The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease. Gastroenterol Clin North Am. 2026 Mar;55(1):165-184. doi: 10.1016/j.gtc.2025.10.003.[...]

Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21.[...]